NCT04412239

Brief Summary

The COVID-19 pandemic might be an opportunity to review and refine our practices in anti TB treatment. For the follow-up of selected patients, telephone consultations may be efficient and cost-effective. The aim of the study is to assess the efficiency and the satisfaction with telephone consultation for the pharmacist and the TB patient. The study was conducted in tertiary care hospital TB control centres patients.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Apr 2020

Shorter than P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 20, 2020

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

May 30, 2020

Completed
3 days until next milestone

First Posted

Study publicly available on registry

June 2, 2020

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 20, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 20, 2020

Completed
Last Updated

November 18, 2020

Status Verified

November 1, 2020

Enrollment Period

8 months

First QC Date

May 30, 2020

Last Update Submit

November 16, 2020

Conditions

Outcome Measures

Primary Outcomes (2)

  • Efficiency of the telephone consultation,

    To improve patient centered care/patient prescription refill

    2 Months

  • Patient satisfaction

    Patient satisfaction Patient satisfaction resulting from pharmacist-led pharmaceutical care will be assessed Patient satisfaction feedback (PSF)

    2 Month

Secondary Outcomes (1)

  • Adherence Rate

    2 Months

Study Arms (1)

Telephone Consultation in TB Patients

EXPERIMENTAL

The COVID-19 pandemic might be an opportunity to review and refine our practices in TB care. For the follow-up of selected patients, telephone consultations may be efficient and cost-effective.

Behavioral: Patient-centred advice on Telephone Consultation in TB Patients:

Interventions

The primary aim was to assess the efficiency and the satisfaction of the telephone consultation. The COVID-19 pandemic might be an opportunity to review and refine our practices in TB care. For the follow-up of selected patients, telephone consultations may be efficient and cost effective.

Telephone Consultation in TB Patients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • New, smear-positive drug-susceptible TB who have been on treatment for less than two weeks Access to a mobile phone (self-reported)

You may not qualify if:

  • Patients who do not have regular access to a mobile phone Patients who have previously received TB treatment Patients who have another member in their household who is already a part of the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Dhq Bannu Kpk

Bannu, KPK, 2800, Pakistan

RECRUITING

District Bannu TB Control Center

Bannu, KPK, 2800, Pakistan

RECRUITING

MeSH Terms

Conditions

Latent TuberculosisPatient Satisfaction

Condition Hierarchy (Ancestors)

TuberculosisMycobacterium InfectionsActinomycetales InfectionsGram-Positive Bacterial InfectionsBacterial InfectionsBacterial Infections and MycosesInfectionsLatent InfectionTreatment Adherence and ComplianceHealth BehaviorBehavior

Central Study Contacts

Farman Ul Khan, Master

CONTACT

Yu Fang, Phd

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Department of Pharmacy Administration and Clinical Pharmacy School of Pharmacy, Health Science Centre Xi'an Jiao tong University.

Study Record Dates

First Submitted

May 30, 2020

First Posted

June 2, 2020

Study Start

April 20, 2020

Primary Completion

December 20, 2020

Study Completion

December 20, 2020

Last Updated

November 18, 2020

Record last verified: 2020-11

Locations